Skip to main content
Clinical Trials/NCT06267755
NCT06267755
Not Yet Recruiting
N/A

Efficacy of Extracorporeal Shockwave Therapy on Ultrasonography Changes of Upper Trapezius Myofascial Trigger Points in Patients With Non Specific Neck Pain

Cairo University0 sites60 target enrollmentFebruary 20, 2024
ConditionsNeck Pain

Overview

Phase
N/A
Intervention
Not specified
Conditions
Neck Pain
Sponsor
Cairo University
Enrollment
60
Primary Endpoint
muscle thickness
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

this study will be conducted to investigate the effect of Extracorporeal Shockwave Therapy on Ultrasonography Changes of Upper Trapezius Myofascial Trigger Points in Patients With Non Specific Neck Pain

Detailed Description

Neck pain is one of the most commonly reported musculoskeletal disorders. The prevalence for neck pain varies between 16.7% and 75.1% in the general population. Up to 67% of world's population may present chronic non-specific neck pain at least once in their lives. The upper trapezius is probably the muscle most often beset by trigger points, it is indicated that the upper trapezius is the most sensitive of 8 different muscles (upper trapezius, pectoralis major, levator scapulae, teres major, supraspinatus, gluteus medius, infraspinatus, paraspinal) to the pressure of an algometer.Recently, the extracorporeal shock wave has been widely known to be an effective therapeutic modality in myofascial pain syndrome treatment and a systematic review provided promising insight into the effectiveness of ESWT in Myofascial pain syndrome treatment. sixty patients with non specific neck pain will be assigned randomly to two groups; first one will receive shock wave therapy and traditional therapy and the second one will receive traditional therapy only for six weeks.

Registry
clinicaltrials.gov
Start Date
February 20, 2024
End Date
August 30, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nabil Mahmoud Ismail Abdel-Aal

principle investigator nabil mahmoud ismail abdel-aal

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Sixty patients receiving a diagnosis of non-specific neck pain with upper trapezius myofascial trigger points by an orthopaedist physician.
  • Body mass index of participants was normal less than (30 kg/m2)(Al-asadi, 2018).
  • Age over 18 years.
  • Presence of taught band.
  • Presence of hyper irritable spot in a taught band, and reproduction of the typical referred pain pattern of the myofascial trigger point in response to compression

Exclusion Criteria

  • Having signs and symptoms of neurological disorders that cause nerve root compression.
  • Headache as a consequence of specific headache diagnosis.
  • Having a history of specific signs of malignancy, or infection.
  • Having a history of trauma with or without proven structural disorders in the region of the neck, shoulder, and head (e.g. whiplash).
  • Having signs and symptoms of cerebrovascular insufficiency.
  • Having a severe chronic disease of the locomotor system (e.g. polyarthritis, muscular disease
  • Any participant with contraindications to shock wave therapy

Outcomes

Primary Outcomes

muscle thickness

Time Frame: up to six weeks

Ultrasonography device will be used to assess muscle thickness

hypoechoic area intensity

Time Frame: up to six weeks

An ultrasonography device will be used to assess the hypoechoic area intensity

Secondary Outcomes

  • neck disability(up to six weeks)
  • cervical range of motion(up to six weeks)
  • pressure pain threshold(up to six weeks)
  • pain intensity(up to six weeks)

Similar Trials